200 related articles for article (PubMed ID: 17538394)
1. Comparative evaluation of 99mTc-depreotide and 201Tl chloride single photon emission tomography in the characterization of pulmonary lesions.
Boundas D; Karatzas N; Moralidis E; Arsos G; Drevelengas A; Pistevou-Gompaki K; Karakatsanis C
Nucl Med Commun; 2007 Jul; 28(7):533-40. PubMed ID: 17538394
[TBL] [Abstract][Full Text] [Related]
2. Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules.
Halley A; Hugentobler A; Icard P; Porret E; Sobrio F; Lerochais JP; Bouvard G; Zalcman G; Agostini D
Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1026-32. PubMed ID: 15877227
[TBL] [Abstract][Full Text] [Related]
3. The solitary pulmonary nodule--is it malignant or benign? Diagnostic performance of Tc-depreotide SPECT.
Naalsund A; Maublant J
Respiration; 2006; 73(5):634-41. PubMed ID: 16679755
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodules.
Grewal RK; Dadparvar S; Yu JQ; Babaria CJ; Cavanaugh T; Sherman M; Jacobstein J
Cancer J; 2002; 8(5):400-4. PubMed ID: 12416898
[TBL] [Abstract][Full Text] [Related]
5. Limited value of ⁹⁹mTc depreotide single photon emission CT compared with CT for the evaluation of pulmonary lesions.
Harders SW; Madsen HH; Hjorthaug K; Rehling M; Rasmussen TR; Pedersen U; Pilegaard HK; Meldgaard P; Baandrup UT; Rasmussen F
Br J Radiol; 2012 Jul; 85(1015):e307-13. PubMed ID: 22745210
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of 99mTc-depreotide and 99mTc-EDDA/HYNIC-TOC thorax scintigrams acquired for the purpose of differential diagnosis of solitary pulmonary nodules.
Płachcińska A; Mikołajczak R; Kozak J; Rzeszutek K; Kuśmierek J
Nucl Med Rev Cent East Eur; 2006; 9(1):24-9. PubMed ID: 16791800
[TBL] [Abstract][Full Text] [Related]
7. A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules.
Blum J; Handmaker H; Lister-James J; Rinne N
Chest; 2000 May; 117(5):1232-8. PubMed ID: 10807805
[TBL] [Abstract][Full Text] [Related]
8. [Fusion of pulmonary scintigraphy with Tc99m-depreotide imaging with CT scan in recognizing solitary pulmonary nodule].
Szaluś N; Chciałowski A; From S; Zagrodzka M; Pietrzykowski J; Dziuk E
Pol Merkur Lekarski; 2008 Oct; 25(148):330-4. PubMed ID: 19145931
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate.
Apostolopoulos DJ; Papandrianos NI; Symeonidis A; Spyridonidis T; Alexiou S; Zampakis P; Savvopoulos C; Vassilakos PJ; Matsouka P
Ann Nucl Med; 2010 Nov; 24(9):639-47. PubMed ID: 20799079
[TBL] [Abstract][Full Text] [Related]
10. Role of scintigraphy with technetium-99m depreotide in the diagnosis and management of patients with suspected lung cancer.
Axelsson R; Herlin G; Bååth M; Aspelin P; Kölbeck KG
Acta Radiol; 2008 Apr; 49(3):295-302. PubMed ID: 18365818
[TBL] [Abstract][Full Text] [Related]
11. Characterization of radiologically indeterminate lung lesions: 99mTc-depreotide SPECT versus 18F-FDG PET.
Ferran N; Ricart Y; Lopez M; Martinez-Ballarin I; Roca M; Gámez C; Carrerea D; Guirao S; Leon AF; Martin-Comin J
Nucl Med Commun; 2006 Jun; 27(6):507-14. PubMed ID: 16710105
[TBL] [Abstract][Full Text] [Related]
12. The utility of two somatostatin analog radiopharmaceuticals in assessment of radiologically indeterminate pulmonary lesions.
Sobic-Saranovic DP; Pavlovic SV; Artiko VM; Saranovic DZ; Jaksic ED; Subotic D; Nagorni-Obradovic L; Kozarevic N; Petrovic N; Grozdic IT; Obradovic VB
Clin Nucl Med; 2012 Jan; 37(1):14-20. PubMed ID: 22157022
[TBL] [Abstract][Full Text] [Related]
13. The value of four imaging modalities to distinguish malignant from benign solitary pulmonary nodules: a study based on 73 cohorts incorporating 7956 individuals.
Wu Q; Zhong L; Xie X
Clin Transl Oncol; 2021 Feb; 23(2):296-310. PubMed ID: 32548796
[TBL] [Abstract][Full Text] [Related]
14. Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy.
Cronin P; Dwamena BA; Kelly AM; Carlos RC
Radiology; 2008 Mar; 246(3):772-82. PubMed ID: 18235105
[TBL] [Abstract][Full Text] [Related]
15. [Technetium99 labelled synthetic somatostatin analogue (depreotide) in the diagnosis of peripheral solitary pulmonary nodules].
Chciałowski A; Dziuk E; From S; Płusa T; Lubiński W; Pietrzykowski J; Zabicka M; Hussain N
Pol Arch Med Wewn; 2004 Sep; 112(3):1031-8. PubMed ID: 15727084
[TBL] [Abstract][Full Text] [Related]
16. Comparative SPECT findings of Tc-99m depreotide, Tc-99m tetrofosmin, and Tl-201 chloride for bronchogenic carcinoma.
Shih WJ; Bensadoun ES; Hirschowitz E; Kieffer V; Gross K
Clin Nucl Med; 2002 Sep; 27(9):676-9. PubMed ID: 12192295
[No Abstract] [Full Text] [Related]
17. A visual and semi-quantitative assessment of (99m)Tc-EDDA/HYNIC-TOC scintigraphy in differentiation of solitary pulmonary nodules.
Płachcińska A; Mikołajczak R; Kozak J; Rzeszutek K; Kuśmierek J
Nucl Med Rev Cent East Eur; 2004; 7(2):143-50. PubMed ID: 15968601
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-depreotide scintigraphy in the evaluation of indeterminate pulmonary lesions: clinical experience.
Martins T; Lino JS; Ramos S; Oliveira L
Cancer Biother Radiopharm; 2004 Apr; 19(2):253-9. PubMed ID: 15186606
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and staging of children's lymphoma using the technetium-labelled somatostatin analogue, 99mTc-depreotide.
Cholewinski W; Kowalczyk JR; Stefaniak B; Stefaniak J; Poniatowicz-Frasunek E; Tarkowska A
Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):820-4. PubMed ID: 14762697
[TBL] [Abstract][Full Text] [Related]
20. Tc-99m depreotide detecting malignant pulmonary nodules: histopathologic correlation with semiquantitative tumor-to-normal lung ratio.
Shih WJ; Samayoa L
Clin Nucl Med; 2004 Mar; 29(3):171-6. PubMed ID: 15162987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
